THEODORE MILLER: Open Payments
NPI 1598316002 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$887 in 48 payments from 10 companies in 2025. Trend: 2023 $309 · 2024 $108 · 2025 $887
Food & beverage: $887
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 24 | $441 |
| Gilead Sciences, Inc. | 9 | $141 |
| Otsuka America Pharmaceutical, Inc. | 4 | $87 |
| Lundbeck LLC | 3 | $65 |
| Novo Nordisk Inc | 3 | $59 |
| Antares Pharma, Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $14 |
| Napo Pharmaceuticals Inc | 1 | $13 |
Products named: APRETUDE, REXULTI, DOVATO, CABENUVA, Ozempic, XYOSTED, MOUNJARO, TRINTELLIX.
Industry payments across NY — which companies pay providers there.
